Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Arrowhead Pharmaceuticals Inc. > Hedge Fund Holdings

Arrowhead Pharmaceuticals Inc. (ARWR)

Market is closed
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Acasta PartnersCV BOND

Mike Humphries

 1,500,000 $1,543,050 0.69%
2.
RWC Asset ManagementNOTE 1/1

Tord Stallvik (Ceo)

 994,000 $1,027,374 -24% 0.04%
3.
Laurion Capital Management

Benjamin A. Smith

 3,484 $228,028 -12% 0%
Insider Monkey Quarterly Strategy
+599.2% Insider Monkey Quarterly Strategy
+227% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
500%
250%
0%

Returns since its inception in May 2014 (through June 2, 2026)

Subscribe Now

30 day money back guarantee. Cancel anytime.

Past performance does not guarantee future returns. Click to see how the portfolio is constructed.